Medicare Supports Capped EPO Payments For ESRD, But Only After Further Study
This article was originally published in The Pink Sheet Daily
Executive Summary
House Ways and Means Committee Chairman Thomas recommends steps to reduce EPO usage in dialysis facilities during a Dec. 6 hearing.
You may also be interested in...
Rep. Thomas Teams Up With Insmed To Promote Follow-on Biologics
Former Rep. Bill Thomas continues his crusade for follow-ons and against Amgen in his new role as consultant to Richmond, Va.-based Insmed, which has big plans for follow-on biologics.
Rep. Thomas Teams Up With Insmed To Promote Follow-on Biologics
Former Rep. Bill Thomas continues his crusade for follow-ons and against Amgen in his new role as consultant to Richmond, Va.-based Insmed, which has big plans for follow-on biologics.
Epoetin Alfa Increases Cardiovascular Risks When Targeting High Hemoglobin Levels, J&J Study Finds
Patients with chronic kidney disease, when treated with a more aggressive dose of Procrit, had a higher risk but no incremental improvement in quality of life.